Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade
1999 StandoutNobel
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
2005
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Angiotensin Receptors and Their Antagonists
1996
Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements
1991
Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study
2007
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study
1999
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
2004
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Elderly heart failure patients with drug-induced serious hyperkalemia
2000
Effects of Low-Sodium Diet vs. High-Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterol, and Triglyceride (Cochrane Review)
2011
Uric Acid and Cardiovascular Risk
2008 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Identification, Distribution, and Expression of Angiotensin II Receptors in the Normal Human Prostate and Benign Prostatic Hyperplasia1
2001
Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors
1993
Aldosterone and antialdosterone therapy in congestive heart failure
1993
A systematic review of the associations between dose regimens and medication compliance
2001 Standout
Gout
2009 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
2004
Functionalizing Glycine Derivatives by Direct CC Bond Formation
2008
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications
2005
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Effects of phosphorothioated neuropeptide Y Y1‐receptor antisense oligodeoxynucleotide in conscious rats and in human vessels
1996
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene
1998 StandoutNobel
Regional distribution of the angiotensinogens in human placentae
1993
Myocyte signalling in leucocyte recruitment to the heart
2014
Gout in Solid Organ Transplantation
2005
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
1991 StandoutNature
Hypertension and current issues in compliance and patient outcomes
2000
Bradykinin receptors: Pharmacological properties and biological roles
1992
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure
2003
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Kinins act on B1 or B2 receptors to release conjointly endothelium‐derived relaxing factor and prostacyclin from bovine aortic endothelial cells
1989 Nobel
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
2011
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
The Cross‐Dehydrogenative Coupling of CH Bonds: A Versatile Strategy for CC Bond Formations
2013 Standout
Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care Organizations
2006
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues
1992
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure
2000
Hemodynamic, Hormonal, and Renal Effects of Short-Term Adrenomedullin Infusion in Healthy Volunteers1
2000
Merlin—rapid analysis of dense genetic maps using sparse gene flow trees
2001 Standout
Aliskiren: the first renin inhibitor for clinical treatment
2008
Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride
1998
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
1989
Converting-Enzyme Inhibitors in the Treatment of Hypertension
1988
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
1999
Adherence to Medication
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Bioorganometallic Chemistry of Ferrocene
2004 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2004 Standout
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
1992
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Bradykinin‐antagonists: Therapeutic perspectives
1989
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution
2003 Standout
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats.
2001
Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
1984
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction
2014
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Renal Hemodynamic Response to an Angiotensin II Antagonist, Eprosartan, in Healthy Men
1997
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Effect of longer-term modest salt reduction on blood pressure
2013
Functionalizing Glycine Derivatives by Direct CC Bond Formation
2008
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
The role of oxidative stress during inflammatory processes
2013
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
2017
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Direct C−H Transformation via Iron Catalysis
2010 Standout
Medication Adherence
2009 Standout
Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors
1988
Acidic residues in extracellular loops of the human Y1 neuropeptide Y receptor are essential for ligand binding.
1994
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
1995 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of B. Waeber being referenced
Control of vascular tone by renin and angiotensin in cardiovascular disease.
1993
Plasma Angiotensin II and the Antihypertensive Action of Angiotensin–Converting Enzyme Inhibition
1989
Cardiovascular Effects of Neuropeptide Y
1988
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo
2010
Prevention of renal hypertension in the rat by neuropeptide Y
1990
Influence of Endogenous Bradykinin on Acute Blood Pressure Response to Vasopressors in Normotensive Rats Assessed with a Bradykinin Antagonist
1988
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
1987
Use of drugs with more than a twenty-four-hour duration of action
1994
Systematic difference between blood pressure readings caused by cuff type.
1994
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
1993
Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans.
1985
Orally active angiotensin‐converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.
1979
Angiotensin-converting enzyme inhibitors in hypertension
1995
Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers
1987
Circulating and Tissue Renin-Angiotensin System
1989
IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY
1999
Effects of the Oral Angiotensin-Converting Enzyme Inhibitor MK-421 in Human Hypertension
1981
The Present Molecules of Converting Enzyme Inhibitors
1985
Effect of Cold Pressor Test on the Internal Diameter of the Radial Artery
1989
Renal Effects of Converting Enzyme Inhibition
1987